Eisai Global
Manufacturing · Japan · 10K+ Employees
View Company Info for Free
Overview
Headquarters
4-6-10 Koishikawa Bunkyo-ku, Tokyo, Toky...Phone Number
+81 338173700Website
www.eisai.comRevenue
$5.1 BillionStock Symbol
ESAIYIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
8
1
2
1
1
1
About Eisai Global
Eisai is a global pharmaceutical manufacturing company founded in 1941. The company develops and produces medicines while focusing on a human health care approach that extends beyond traditional pharmaceutical services. Eisai operates across multiple regions including North America, Europe, Asia Pacific, and the Middle East, with a strong presence in countries such as the United States, Japan, China, and the United Kingdom. The company maintains a significant focus on research and development in the pharmaceutical sector, with particular emphasis on patient-centered healthcare solutions. Eisai's business model encompasses both business-to-business and business-to-consumer operations, reflecting its comprehensive approach to healthcare delivery and pharmaceutical development.Explore more
Eisai Global Org Chart
PF
Vice President and General Manager
SY
Vice President
KA
Vice President
JK
Vice President, Clinical Development
JZ
Vice President and Head of MBE Division
SS
Vice President, China Business Japan, Asia Fi...
MK
Strategy Vice President, Supply Chain
LO
Vice President, Quality Operations
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eisai Global your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Eisai Global, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Eisai Global
Click to see if Eisai Global had a recent Job posting/layoffs
Product Launch: Get notified when Eisai Global launches new products
Funding: Get notified immidiatlly once Eisai Global has new funding data
Check out if Eisai Global is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Eisai Global recently announced quarterly report
Check if Eisai Global has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Eisai Global
Find more new buyers
Compare Similar Companies to Eisai Global
Compare insights from companies similar to Eisai Global, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Eisai Global
$5.1B
10K+
Public
-
1941
Tatsuyuki YasunoChairman & CEO & Eisai Inc Region President (Americas)
$48.5B
10K+
Public
$4B
1887
IC
Imara CharlesVice President, Chief of Staff, Global Product Development & Supply
Company Profile Activity
Activity Insights
Eisai Global is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Eisai Global is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Eisai Global.
Eisai Global Tech Stack
A closer look at the technologies used by Eisai Global
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Eisai Global News & Media
UCL and Eisai renew partnership to accelerate treatments for neurodegenerative diseases
TOKYO, July 2, 2026 - (JCN Newswire) - University College London (UCL) and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito) have signed a new agreement to extend their long-standing collaboration in drug discovery and development for five more years, taking the partnership through to 2030. This alliance reinforces a unique model built on trust, combining academic excellence with industry expertise to accelerate innovation in neuroscience drug discovery, investigating new ways of treatingEisai Announces Strategic Investment Supported by the UK Government's LSIMF
TOKYO, June 17, 2026 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) today announced a strategic investment supported by the UK Government under the Life Sciences Innovative Manufacturing Fund (LSIMF), subject to terms and conditions, at its manufacturing site in Hatfield, Hertfordshire, United Kingdom, to establish supply chain and packaging capabilities for current and future medicines that require cold-chain management, including lecanemab. LSIMF is a capitEisai Deepens Body of Clinical Evidence for LENVIMA (Lenvatinib) Across Established Indications at ASCO 2026
Real-World Evidence to be Presented Comparing First-Line Lenvatinib Versus Dabrafenib Plus Trametinib in BRAF-Mutated Differentiated Thyroid Cancer Additional Analysis from the Pivotal Phase 3 CLEAR Trial Examines Efficacy Outcomes by Patterns of Progression in Advanced Renal Cell...Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease
TOKYO and CAMBRIDGE, Mass., May 8, 2026 /PRNewswire/ -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period by three months for the supplemental Biologics License Application (sBLA) for a...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Eisai Global
Sign Up For FreeTo access detailed company insights
Eisai is a global pharmaceutical manufacturing company founded in 1941. The company develops and produces medicines while focusing on a human health care approach that extends beyond traditional pharmaceutical services. Eisai operates across multiple regions including North America, Europe, Asia Pacific, and the Middle East, with a strong presence... Read More
